151 related articles for article (PubMed ID: 10363275)
21. Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinoma.
Hua YJ; Chen MY; Qian CN; Hong MH; Zhao C; Guo L; Guo X; Cao KJ
Head Neck; 2009 Jun; 31(6):807-12. PubMed ID: 19340873
[TBL] [Abstract][Full Text] [Related]
22. Electromyographic study on the effects of radiation applied to the spinal cord.
Kuroda Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1966 Oct; 26(7):927-36. PubMed ID: 5232006
[No Abstract] [Full Text] [Related]
23. Radiation myelitis of the dorsolumbar spinal cord.
Maier JG; Perry RH; Saylor W; Sulak MH
Radiology; 1969 Jul; 93(1):153-60. PubMed ID: 5801130
[No Abstract] [Full Text] [Related]
24. Ruptured internal carotid pseudoaneurysm in a nasopharyngeal carcinoma patient with skull base osteoradionecrosis.
Chen HC; Lin CJ; Jen YM; Juan CJ; Hsueh CJ; Lee JC; Su WF
Otolaryngol Head Neck Surg; 2004 Mar; 130(3):388-90. PubMed ID: 15054390
[No Abstract] [Full Text] [Related]
25. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
[TBL] [Abstract][Full Text] [Related]
26. [Intensity modulated radiation therapy for 49 patients with recurrent nasopharyngeal carcinoma].
Lu TX; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Zeng ZF; Huang SM; Lin CG; Cui NJ
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):386-9. PubMed ID: 12921573
[TBL] [Abstract][Full Text] [Related]
27. Choanal stenosis: an unusual late complication of radiation therapy for nasopharyngeal carcinoma.
Shepard PM; Houser SM
Am J Rhinol; 2005; 19(1):105-8. PubMed ID: 15794084
[TBL] [Abstract][Full Text] [Related]
28. Ophthalmic involvement in nasopharyngeal carcinoma.
Wong WM; Young SM; Amrith S
Orbit; 2017 Apr; 36(2):84-90. PubMed ID: 28388349
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
30. Middle ear effusions after radiotherapy: correlation with pre-radiotherapy nasopharyngeal tumor patterns.
Kew J; King AD; Leung SF; Tong MC; Ku PK; Wong KK; van Hasselt CA
Am J Otol; 2000 Nov; 21(6):782-5. PubMed ID: 11078063
[TBL] [Abstract][Full Text] [Related]
31. [Influence of various irradiation rhythms on neoplastic and normal tissue in vivo].
Eichhorn HJ; Lessel A; Rotte KH
Strahlentherapie; 1972 Jun; 143(6):614-29. PubMed ID: 5071559
[No Abstract] [Full Text] [Related]
32. Radiation myelopathy in relation to oxygen level.
Coy P; Dolman CL
Br J Radiol; 1971 Sep; 44(525):705-7. PubMed ID: 5569966
[No Abstract] [Full Text] [Related]
33. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
34. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.
Oh YT; Kim CH; Choi JH; Kang SH; Chun M
Radiother Oncol; 2004 Jul; 72(1):79-82. PubMed ID: 15236878
[TBL] [Abstract][Full Text] [Related]
35. [Late neurotoxicity after nasopharyngeal carcinoma treatment].
Siala W; Mnejja W; Khabir A; Ben Mahfoudh K; Boudawara T; Ghorbel A; Frikha M; Daoud J
Cancer Radiother; 2009 Dec; 13(8):709-14. PubMed ID: 19695928
[TBL] [Abstract][Full Text] [Related]
36. Radiation myelopathy in patients treated for carcinoma of bronchus using a six fraction regime of radiotherapy.
Dische S; Martin WM; Anderson P
Br J Radiol; 1981 Jan; 54(637):29-35. PubMed ID: 7448497
[TBL] [Abstract][Full Text] [Related]
37. Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancer.
Hui EP; Sung FL; Yu BK; Wong CS; Ma BB; Lin X; Chan A; Wong WL; Chan AT
Clin Cancer Res; 2008 Nov; 14(21):7080-7. PubMed ID: 18981006
[TBL] [Abstract][Full Text] [Related]
38. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.
Lee AW; Ng WT; Hung WM; Choi CW; Tung R; Ling YH; Cheng PT; Yau TK; Chang AT; Leung SK; Lee MC; Bentzen SM
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1121-8. PubMed ID: 18723296
[TBL] [Abstract][Full Text] [Related]
39. Delayed radiation myelopathy in man. Report of twelve necropsy cases.
Jellinger K; Sturm KW
J Neurol Sci; 1971 Dec; 14(4):389-408. PubMed ID: 5125754
[No Abstract] [Full Text] [Related]
40. Complications of therapy and a diagnostic dilemma case. Case 1. Radiation maculopathy following treatment of nasopharyngeal carcinoma.
Cackett P; Stebbing J; Dhillon B
J Clin Oncol; 2003 Dec; 21(24):4650-1. PubMed ID: 14673055
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
